New drug tested to protect kids on chemo from dangerous infections
NCT ID NCT04570423
Summary
This study is testing the safety and how the body processes a drug called eflapegrastim in children with solid tumors or lymphoma. The drug is given alongside standard chemotherapy and aims to help the body rebuild white blood cells, which are crucial for fighting infections. The goal is to see if this drug can safely reduce the risk of serious infections and low white blood cell counts that are common side effects of chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Carolinas Medical Center/ Levine Children's Hospital
TERMINATEDCharlotte, North Carolina, 28203, United States
-
Levine Children's Health
TERMINATEDCharlotte, North Carolina, 28203, United States
-
New York Medical College
TERMINATEDValhalla, New York, 10595, United States
-
UT MD Anderson Cancer Center
TERMINATEDHouston, Texas, 77030, United States
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.